Fed State Budgetary Inst "N.N. Blokhin Med Center of Oncology" MHRF

Moskva, Moscow Oblast 115478

0 studies enrolling now · 1 studies all time

What they study most

Triple-Negative Breast Cancer

Studies at this site

• A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer — Completed